Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Axonics Modulation Technologies IncAXNX-640.598.395.78113.84-0.89%-1.71%46.54$69.67$226.46657,537$70.97

Detail of Axonics Modulation Technologies Inc

 
CEO
Mr. Raymond W. Cohen
Employees
797
Industry
Medical Devices
Sector
Healthcare
Market cap
$4B

Company details

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California. As of November 15, 2024, Axonics, Inc. operates as a subsidiary of Boston Scientific Corporation.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$431.90M
Cost of goods (CoG)
-$101.10M
Gross profit (GP)
$330.81M
Operating expense (OE)
-$329.04M
Research and development (R&D)
-$47.05M
General and administrative (G&A)
-$281.99M
Operating income (OI)
-$7.22M
Other income expense (OIE)
-$13.48M
Pretax income (PI)
-$3.01M
Tax (TAX)
-$2.65M
Net income (NI)
-$5.66M
Axonics Modulation Technologies Inc
AXNX • XNGS • US
$70.97
+13.77 (24.07%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$0.11
Margin profit
-1.31%
52 week low
$56.189999
52 week high
$70.980003
50-day simple moving average
$70.40
200-day simple moving average
$69.67
Percent held by insiders
1.26%
Percent held by institutions
87.22%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
AXNX +23.77%
eps change
AXNX -100.51%